InvestTech Advanced Solutions

📢 Attention all aspiring investment professionals, marketing professionals and data analysts 🧑‍🔬👩‍🔬

InvestTech Advanced Solutions is excited to announce its new Summer 2023 internship programme! This is an incredible opportunity for a few brilliant minds to gain valuable work experience in InvestTech, marketing, data science and industry analytics.

Selected interns will work on world-leading research and operations, and gain exclusive opportunities to network with global leaders and visionaries. This is the chance to learn from the best and take your career to the next level.

Do you know someone who would be perfect for this internship? Tag them in the comments below and let them know about this incredible opportunity!

For more information and to apply, visit the InvestTech Advanced Solutions website today https://eu1.hubs.ly/H04mkqc0

Don't miss out on this chance to make a difference in the field of InvestTech! 🌟

A message from our General Partner, Dmitry Kaminskiy:

"On behalf of Deep Knowledge Group, I would like to wish all of our allies, partners, supporters, and collaborators a very happy, productive, and New Year.

2022 was a year marked by countless key defining moments - many of which were largely unanticipated, taking the global economy through an unventured path. However, Deep Knowledge Group has always responded to unprecedented challenge by transforming it into newfound via decisive action, and we saw this principle precisely reflected by the sophisticated and breakthrough work done by its many skilled team members across the globe this year, who channeled the raw energy of the challenges they faced into highly complex projects and advanced technical outcomes at the intersection of , , and .

We have made significant progress over the past year in our quest to achieve this vision via the active prioritisation of projects focused on , Impact Investments, and Longevity Industry Financial Commoditization, and . Through the development of our platforms, technologies and projects we pushed beyond the norm, building international collaborations, creating social impact and powering global initiatives. These milestones extended our reach from Europe to the Gulf region, Asia, and North America.

As we begin this new year and push for even newer frontiers, we hope that you find the strength to do the same.

Once again, I wish you all the best of the New Year - more Prosperity, more Healthy Longevity, and more DeepTech for Techno-Ethical Universal Good. 🎉

Kind Regards,
Dmitry Kaminskiy"

The United Kingdom is at the forefront of the global Longevity financial industry in terms of innovation and market share.

The country is among the economies having an increasing lifespan of its population, and, therefore, the UK is building the ecosystem aimed to tackle the challenges associated with that.

From the geographical perspective, the London area is represented by the largest number of companies providing services and solutions in the Longevity financial industry.

View our latest Longevity Financial Industry in the United Kingdom report at: https://eu1.hubs.ly/H01tws_0

Deep Knowledge Group aims to bridge the liquidity gap hindering DeepTech and Longevity development globally and hosted on 𝐋𝐨𝐧𝐠𝐞𝐯𝐢𝐭𝐲 𝐅𝐢𝐧𝐓𝐞𝐜𝐡 𝐚𝐧𝐝 𝐈𝐧𝐯𝐞𝐬𝐭𝐓𝐞𝐜𝐡 event for Longevity Financial Club, in the Sky Lounge of the landmark The Shard London building

This event, moderated by Dominic Jennings, hosted a spectacular lineup of leaders, founders and industry influencers as panel speakers:

- Dmitry Kaminskiy, Managing Partner at Deep Knowledge Group
- Sean Tai, CEO, and Founder of PTE LTD
- Elena Kozhemyakina, CEO at FinTech4Funds
- Daniel Ballin, CEO at Ideas Crucible
- Prof. Michael Miller, World Health Organization (WHO) Digital Health Technical Advisor
- Dominic Jennings, Head of Strategic Partnerships, Longevity Financial Advisors
- Talgat Takiyev, Head of Investor Relations for UK and Europe region at Deep Knowledge Group

Our panel speakers shared deep insights, interesting findings, and personal experiences about trending topics in different sectors such as:

- Fintech, ,
- and Longevity Private Equity
- Gap - Problem and Solution
- Modern Approaches in
- AI and in Longevity

We thank every one of our attendees who were a part of this event. You made it a great success!

📌 https://www.longevity.network/london-longevity-fintech-july2022

In Q1 2022 most of the IPOs took place in the US. The second place by the number of IPOs is in Asia and the UK closes the list, we saw 13 Longevity companies successfully completed their IPO, and 4 of them went public through the combination with S**Cs.

Their total capitalisation accounted for $4.7 billion as of March 2022. The biggest valuation at IPO had Asieris Pharmaceuticals ($2.06 billion), a biotech company focusing on therapeutic areas in oncology and multidrug-resistant infections.

Among IPO which went by S**C the biggest valuation of $1.2 billion was received by GreenLight Biosciences which went public after merging with Nasdaq-listed special purpose acquisition company (S**C) Environmental Impact Acquisition Corp.

Check out our report about Longevity Industry at: https://eu1.hubs.ly/H01nj570

The Longevity Industry has been actively growing over the whole of 2021 and is projected to evolve in the same trend. After facing a little turbulence at the beginning of 2022 the market capitalisation of 500 publicly traded companies is slightly below $5.5 trillion.

We can see medium funding rounds of prominent companies in Q1 2022 as following:

Medically Home, is a tech-enabled clinical enterprise that provides all the necessary capabilities to safely-shift medical care from hospitals to patients’ homes, picked $110 million in a funding from strategic investors including Baxter International, Global Medical Response (GMR), and Cardinal Health.

MindMaze, a digital neurotherapeutic platform, provides digital assessments and therapeutics to treat and rehab patients. It offers patients to engage with motivational virtual reality rehabilitation programs that support their recovery goals enabling them to follow a personalised exercise regimen prescribed by the rehabilitation expert. In February the company MindMaze secured $105 million financing, led by Concord Health Partners.

ConcertoCare, serves patients with Medicare+Medicaid, Medicare Advantage or Medicare, who have complex care needs and an existing primary care provider. The company scored a $105 million series B funding to scale its care model to provide comprehensive health services to more seniors with unmet health and social needs in their homes in February 2022.

MeMed , a personalised diagnostics company with main focus on preventing antibiotics misuse (improve patient care, empower physicians, and lower health-care costs through rapid and actionable diagnostics for infectious diseases).

Celsius Therapeutics, a biotechnology company that develops precision medicines for cancer and autoimmune disease patients, raised a total of $83M from Third Rock Ventures, Section 32, GV and others.

Check out our report about Longevity Industry at: https://eu1.hubs.ly/H01fvdf0

PharmTech and P4 Medicine are Longevity sub-sectors involving the largest number of companies and receiving the highest volume of investments ($130.7 billion and $85.4 billion, respectively) within private companies.

Among 500 Longevity-focused public companies, PharmTech, P4 Medicine and Deep Diagnostics are the most represented sectors by a number of companies.

Check out our report and learn more about Longevity Industry here: https://eu1.hubs.ly/H0165Jp0